**Meet the editor**

Dr. Alba Fabiola Costa Torres has a Bachelor's degree in Pharmaceutical Sciences (2005) and an Improvement Course in Industrial Pharmacy (2007) from the Federal University of Paraiba, UFPB, Joao Pessoa, Brazil; a Master's degree in Pharmaceutical Sciences (2009) and a PhD in Development and Technological Innovation of Medicines (2013) from the Federal University of

Ceara, UFC, Fortaleza, Brazil; and a Post-Doctoral fellowship in Pathology/ Oncology from Johns Hopkins Medical School, JHMI, Baltimore, United States (2017). During the last few years the development of knowledge and technical/scientific experience in surgical pathology/oncology has been a major field of work, with urological and thoracic pathology being the main subarea of interest.

Contents

**Preface VII**

Jelena Stojšić

Dilaver Tas

**Contribute 79**

**Section 1 Insights on Diagnosis of Lung Cancer 1**

**First Step in Personalized Therapy 3**

Chapter 2 **Paraneoplastic Syndromes in Lung Cancer 23**

Chapter 4 **Diagnosis of Lung Cancer: What Metabolomics Can**

Chapter 5 **Immunotherapy in Advanced Lung Cancer Treatment 97**

Chapter 6 **Epigenetic Modifications and Potential Treatment Approaches**

Chapter 7 **The Immune Regulatory Role of Cytokine-Induced Killer Cells Treatment on Non-Small Cell Lung Cancer Patients 137**

**Section 2 Insights on Treatment of Lung Cancer 95**

Metin Budak and Mustafa Yildiz

Alexandru C. Grigorescu

**in Lung Cancers 115**

Li Zhang and Yanyan Pan

Chapter 1 **Precise Diagnosis of Histological Type of Lung Carcinoma: The**

Chapter 3 **Pleural Effusions in Lung Cancer: Detection and Treatment 43** Milic Medenica, Miras Medenica and Danilo Cosovic

> Elien Derveaux, Evelyne Louis, Karolien Vanhove, Liene Bervoets, Liesbet Mesotten, Michiel Thomeer and Peter Adriaensens
